IP Library Granted Patent US 10,731,172
Granted Patent B2
US 10,731,172 · App. 16/003,066 · Granted Aug 4, 2020

Regulating alkaloids

Inventors: Takashi Hashimoto (Ikoma, JP); Akira Kato (Nara, JP)
Assignee: 22nd Century Limited, LLC
C12N15/8218A24B13/00A24B15/10A61K31/455C12N9/0004C12N9/0012C12N9/0022C12N15/8216C12N15/8243C12N15/8279C12N15/8286C12Y104/03006Y02A40/162
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,731,172
App. No.
16/003,066
Granted
Aug 4, 2020
Kind
B2
Abstract

MPO1 and MPO2 can be regulated for either decreasing or increasing alkaloid levels in plants, in particular in Nicotiana plants. In particular, suppressing or overexpressing one or more of MPO1 and MPO2 may be used to decrease or increase nicotine and nicotinic alkaloid levels in tobacco plants. Suppression or overexpression of one or more of MPO1 and MPO2 may be used in combination with modification of expression of other genes encoding enzymes on the nicotinic alkaloid biosynthetic pathway such as A622, NBB1, PMT, and QPT.

Claims (13)

1. A method for increasing nicotine and yield in a Nicotiana plant, comprising:

(a) introducing into a Nicotiana tabacum plant a construct comprising, in the 5′ to 3′ direction, a promoter operably linked to a heterologous nucleic acid encoding an enzyme that increases yield selected from pathogenesis-related maize seed (PRms) gene, fructose-1,6-/sedoheptulose-1,7-biosphospatase, fructose-1,6-bisphosphatase, and sedoheptulose-1,7-bisphosphatase;

(b) introducing into the Nicotiana plant a vector comprising a nucleotide sequence selected from the group consisting of:

(i) the nucleotide sequence set forth in SEQ ID NO: 3;

(ii) a nucleotide sequence that encodes a polypeptide having the amino acid sequence set forth in SEQ ID NO: 4;

(iii) the nucleotide sequence set forth in SEQ ID NO: 1;

(iv) a nucleotide sequence that encodes a polypeptide having the amino acid sequence set forth in SEQ ID NO: 2; and

(v) any combination of (i)-(iv);

(c) regenerating transgenic Nicotiana tabacum plants from the plant; and

(d) selecting a transgenic Nicotiana tabacum plant having increased nicotine content and increased yield relative to a control Nicotiana tabacum plant.

2. An increased nicotine and yield Nicotiana tabacum plant produced by the method claim 1 .

3. An increased nicotine product produced from the Nicotiana tabacum plant of claim 2 .

4. The increased nicotine product of 3, wherein the product is selected from the group consisting of a cigarette, a pharmaceutical, and a nutraceutical.

Assignments (2)
PATENT SECURITY AGREEMENT Recorded Mar 29, 2023
From: 22ND CENTURY GROUP, INC.
To: JGB COLLATERAL, LLC
Reel/Frame 063188/0812 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 19, 2021
From: NARA INSTITUTE OF SCIENCE AND TECHNOLOGY
To: 22ND CENTURY LIMITED, LLC
Reel/Frame 055657/0765 →
Continuity (4)
Division 14822105 · Aug 10, 2015
Division 11941950 · Nov 18, 2007
Provisional Application 60866352 · Nov 17, 2006
Related Publication 20180273967A1 · Sep 27, 2018